Immune control of HIV-1 after early treatment of acute infection

References

Page 1

	Year	Citations
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function Allan Zajac, Joseph N. Blattman, Kaja Murali‐Krishna, The Journal of Experimental Medicine Immunological MemoryViral PersistenceAutoimmune DiseaseAdaptive Immune SystemCd8 T Cells	1998	1.9K
Vigorous HIV-1-Specific CD4 <sup>+</sup> T Cell Responses Associated with Control of Viremia Eric Rosenberg, James M. Billingsley, Angela M. Caliendo, Science	1997	1.8K
Positive Effects of Combined Antiretroviral Therapy on CD4 <sup>+</sup> T Cell Homeostasis and Function in Advanced HIV Disease Brigitte Autran, Guislaine Carcelain, T. S. Li, Science	1997	1.8K
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus Franziska Lechner, David Wong, P. Rod Dunbar, The Journal of Experimental Medicine	2000	1.3K
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection Mehrdad Matloubian, R J Concepcion, R Ahmed Journal of Virology	1994	1.1K
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Richard T. Davey, Niranjan Bhat, Christian Yoder, Proceedings of the National Academy of Sciences	1999	849
Antiretroviral Therapy for HIV Infection in 1997 Charles C. J. Carpenter JAMA	1997	728
Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C J. Tilman Gerlach, Helmut M. Diepolder, Maria–Christina Jung, Gastroenterology Acute Hepatitis CViral PersistenceHepatologyHepatitis CHepatitis C Virus	1999	706
New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes Robert S. Janssen JAMA	1998	697
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV Giuseppe Pantaleo, James F. Demarest, Hugo Soudeyns, Nature Adaptive Immune SystemHuman RetrovirusMajor ExpansionPredominant Vβ UsageImmune Regulation	1994	605

Page 1